| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,623 | 130,557 | 133,524 | 134,491 | | Cost of Revenue | 1,811 | 21,479 | 22,711 | 25,652 | | | Gross Profit |
-
| 109,078 | 110,813 | 108,839 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,747 | 79,291 | 72,241 | 71,886 | | Non Recurring |
-
|
-
|
-
| 39,349 | | Others | (8,963) | 27,235 | 18,823 | 26,922 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,552 | 19,749 | (29,318) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 15,028 | 2,552 | 19,749 | (29,427) | | Interest Expense | 6,413 | 12,237 | 12,540 | 14,533 | | Income Before Tax | 8,615 | (9,685) | 7,209 | (43,960) | | Income Tax Expense | 2,025 | (2,417) | 2,021 | (19,041) | | Minority Interest | (1,137) | (1,344) |
-
| (109) | | | | Net Income From Continuing Ops | 7,934 | (8,612) | 5,188 | (24,919) | | | Non-recurring Events | | Discontinued Operations | (36,813) | (318) | (1,875) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (31,360) | (8,930) | 3,313 | (24,919) | | Preferred Stock And Other Adjustments | (9,851) | (7,655) | (8,851) | (33,029) | | | Net Income Applicable To Common Shares | ($41,211) | ($16,585) | ($5,538) | ($57,948) |
|
0.31% Nasdaq 
0.05%
Income Statement
